Midterm Study Questions Flashcards

1
Q

What is the main weakness of the RCT?

A

Not always generalizable to the lager public because they are so tightly controlled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

3 different types of randomization

A
  1. Simple randomization
  2. Stratification randomization
  3. Block randomization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is simple randomization and what are limits/strengths?

A

Random number tables, tossing a coin, drawing different colored balls, etc.

+ It is simple, and when done with integrity it’s difficult to go wrong

  • can suffer from ‘chance bias’
  • groups may end up with unequal numbers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is stratification randomization and limits/strengths?

A

In simple randomization you can end up with unbalanced groups in co-variate.

Stratification identifies covariates in the population and ensures they are evenly distributed between treatment groups

+ identical numbers in each group (NOT most important)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is block randomization and what are limits/strengths?

A

Can balance the numbers in the group at anytime during the trial

+ ensures identical numbers in each group

  • can lead to prediction of group allocation if block size is guessed. Does not guarantee all covariates are equally distributed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is it that RCTs can demonstrate that cohort, case control, and case series studies cannot do?

A

Establishes causation (not just correlation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does each letter of the ABCDFIX tool stand for?

A

allocation, blinding, comparable groups, dropouts, follow-up, intention to treat, X-factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do the numbers mean in 2-6?

A
  • 2 acceptable methods to allocate
  • 3 need to be blinded: patients, providers, outcome measureres
  • 4 comparison groups
  • 5 dropouts? 5% is ok, more than 20% is hard to make outcomes valid
  • 6 follow-up length 6 months to a year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the most common acceptable ways to ensure that subject allocation is concealed?

A

1) computerized allocation (not just computerized randomization) from an off-site location or
2) on site allocation via sealed opaque envelops preferable by an independent agent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Can allocation be concealed even if the patients, doctors and outcome measures are not blinded?

A

Yes. Blinding and allocation are different.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 4 Cs?

A

C = group comparisons

  1. Comparable at baseline (start)?
  2. Comparable co-interventions?
  3. Comparable attention?
  4. Comparable compliance?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Who are the 3 most important participants in an RCT to blind?

A

Doctor, Patient, Outcome Assessor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is response bias?

A

Patients report symptoms in a way to please the provider

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Who else can be blinded?

A

statistician, adjuticator, research assistants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is an adjudicator?

A

An adjudicator is someone who presides, judges, and arbitrates during a formal dispute or competition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are 5 things that are good to check when looking at drop outs?

A

study should report:

  • Total number of drop outs
  • Number of drop outs per group
  • When they dropped out
  • The reason they dropped out
  • Whether or not patients dropping out were similar to those who stayed
17
Q

What is the 5-20 rule? How is it used?

A

In most cases <5% drop outs do not threaten the results too much (but an ITT analysis should still have been done), 10-20% is a bigger threat and an ITT analysis or similar approach is expected, and >20% is such a big loss, that even an ITT analysis may not be able to offset the challenge to the validity of the outcomes.

18
Q

What is a reasonably good length of time for follow up in a musculoskeletal study?

A

6 months to a year

19
Q

What are four different types of “control” groups used in RCTs?

A
  1. Receive experimental therapy
  2. Receive the “usual” therapy
  3. Receive a placebo therapy
  4. Receive nothing
20
Q

What are methods to deal with or prevent uneven distribution of confounders after randomization?

A
  • Per-protocol analysis
  • IIT
  • Worst-case analysis
  • Or both IIT and per-protocol analysis
21
Q

What are the advantages of ITT analysis?

A

Corrects drop outs:

  • Preserves randomization
  • Helpsmaintainprognosticbalance
  • Preservessamplesizebalance
  • Helps prevent an overestimation of how good a treatment really is
  • Betterreflectsrealpractice
22
Q

What are the challenges of creating a sham group for interventions like manipulation and acupuncture?

A

Hard to implement the placebo effect

23
Q

What method of ITT is thought to be the weakest?

A

Per-protocol results because it does not account for potential effects of dropouts or crossovers

24
Q

Where are two places (outside the abstract) where one can usually find out if an intention to treat
analysis was done?

A

Methodology or result section of the paper

25
Q

Order the proper sequence of the steps of an RCT:

A
  • sampling
  • application of inclusion and exclusion criteria
  • randomization
  • allocation
  • assessing baseline characteristics
  • treating and monitoring during the intervention phase
  • post intervention follow up
  • statistical analysis
  • adjusting results as necessary
26
Q

What are some of the x factors that can challenge internal validity?

A
  • Conflict of interest
  • Was therapy given at an acceptable “therapeutic” dose
  • We’re the outcome measures used to judge success validated and are they accurate?
  • Was the sampling process flawed?